TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $68,722,000 | +203.1% | 913,245 | +8.1% | 0.02% | +220.0% |
Q1 2022 | $22,674,000 | -40.7% | 844,461 | +5.4% | 0.01% | -37.5% |
Q4 2021 | $38,218,000 | -20.1% | 801,209 | +11.2% | 0.01% | -20.0% |
Q3 2021 | $47,847,000 | -15.5% | 720,263 | -0.8% | 0.01% | -23.1% |
Q2 2021 | $56,650,000 | +45.8% | 726,104 | +76.8% | 0.01% | +30.0% |
Q1 2021 | $38,855,000 | -39.6% | 410,782 | -22.2% | 0.01% | -41.2% |
Q4 2020 | $64,362,000 | +67.0% | 528,209 | +19.7% | 0.02% | +54.5% |
Q3 2020 | $38,550,000 | +47.1% | 441,273 | +8.7% | 0.01% | +37.5% |
Q2 2020 | $26,215,000 | +201.0% | 405,855 | +108.1% | 0.01% | +166.7% |
Q1 2020 | $8,710,000 | +21.8% | 195,034 | +69.9% | 0.00% | +50.0% |
Q4 2019 | $7,150,000 | +489.9% | 114,790 | +256.1% | 0.00% | – |
Q3 2019 | $1,212,000 | +411.4% | 32,237 | +453.4% | 0.00% | – |
Q2 2019 | $237,000 | – | 5,825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |